4//SEC Filing
Dinsmore Christopher 4
Accession 0001209191-24-001067
CIK 0001741830other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 6:30 PM ET
Size
5.3 KB
Accession
0001209191-24-001067
Insider Transaction Report
Form 4
Kronos Bio, Inc.KRON
Dinsmore Christopher
Chief Scientific Officer
Transactions
- Sale
Common Stock
2024-01-04$1.18/sh−7,366$8,718→ 260,969 total
Footnotes (2)
- [F1]Represents shares sold to satisfy estimated tax withholding obligations upon the settlement of restricted stock units.
- [F2]The weighted average sale price for the transaction reported was $1.1836, and the range of prices were between $1.12 to $1.28. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Documents
Issuer
Kronos Bio, Inc.
CIK 0001741830
Entity typeother
Related Parties
1- filerCIK 0001826766
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 6:30 PM ET
- Size
- 5.3 KB